Article Details

aTyr Pharma (NASDAQ:LIFE) Downgraded to "Hold" at Zacks Investment Research

Retrieved on: 2021-01-12 20:37:30

Tags for this article:

Click the tags to see associated articles and topics

aTyr Pharma (NASDAQ:LIFE) Downgraded to "Hold" at Zacks Investment Research. View article details on hiswai:

Excerpt

Acadian Asset Management LLC now owns 83,052 shares of the biotechnology company's stock worth $269,000 after acquiring an additional 15,088 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up